FDA approves Astellas' gastric cancer therapy
18/10/2024 17:24
Oct 18 (Reuters) - The U.S. Food and Drug Administration approved Astellas' 4503.T gastric cancer therapy, the health regulator's website showed on Friday. (Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn